Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Structural Characteristics for Inhibition of [3H] Norepinephrine Uptake into Rat Brain Synaptic Vesicles by Beta-Carboline, Indolealkylamine, Phenethylamine and n-Alkylamine Derivatives

THEODORE A. SLOTKIN, MARIA SALVAGGIO, FREDERIC J. SEIDLER and WILLIAM L. WHITMORE
Molecular Pharmacology May 1979, 15 (3) 607-619;
THEODORE A. SLOTKIN
Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA SALVAGGIO
Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FREDERIC J. SEIDLER
Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WILLIAM L. WHITMORE
Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 15 no. 3 607-619
PubMed 
492148

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online May 1, 1979.

Copyright & Usage 
Copyright © 1979 by Academic Press, Inc.

Author Information

  1. THEODORE A. SLOTKIN,
  2. MARIA SALVAGGIO,
  3. FREDERIC J. SEIDLER, and
  4. WILLIAM L. WHITMORE
  1. Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710

Statistics from Altmetric.com

Article usage

Article usage: September 2005 to September 2023

AbstractFullPdf
Sep 2005102
Oct 2005002
Nov 2005100
Dec 2005300
Jan 2006100
Mar 2006909
Apr 2006200
May 2006100
Jun 2006100
Oct 2006301
Nov 2006100
Jan 2007100
Feb 2007100
Mar 2007200
Apr 2007100
May 2007500
Jun 2007300
Aug 2007201
Sep 2007001
Oct 2007001
Nov 2007001
Feb 2008100
Mar 2008200
Apr 2008100
Jun 2008200
Aug 2008201
Sep 2008401
Oct 2008400
Nov 2008300
Jan 2009100
Feb 2009100
Apr 2009101
Aug 2009100
Sep 2009500
Oct 2009500
Nov 2009400
Dec 2009400
Jan 2010100
Feb 2010301
Mar 2010100
Apr 2010200
May 2010200
Jun 2010104
Jul 2010100
Sep 2010100
Oct 2010300
Nov 2010400
Dec 2010600
Jan 2011703
Feb 2011600
Mar 2011700
Apr 2011700
May 2011800
Jun 2011400
Jul 2011700
Aug 2011500
Sep 2011600
Oct 2011901
Nov 20111000
Dec 2011700
Jan 20121101
Feb 2012500
Mar 2012800
Apr 20121200
May 2012700
Jun 2012800
Jul 20121000
Aug 2012703
Sep 2012900
Oct 20122300
Nov 20121600
Dec 20121101
Jan 2013900
Feb 20131700
Mar 20132206
Apr 20132600
May 20133000
Jun 2013602
Jul 2013500
Aug 2013701
Sep 2013800
Oct 2013700
Nov 2013900
Dec 2013700
Jan 20141300
Feb 20141100
Mar 20141100
Apr 20141900
May 20141200
Jun 20141200
Jul 20141700
Aug 20141600
Sep 20141000
Oct 20141600
Nov 20141300
Dec 20141700
Jan 20151400
Feb 20151200
Mar 20151400
Apr 20151500
May 20151600
Jun 20151500
Jul 20151400
Aug 20151101
Sep 2015200
Oct 2015800
Nov 20151600
Dec 20151300
Jan 20161300
Feb 20161802
Mar 20161800
Apr 20161701
May 20161300
Jun 20161500
Jul 20161200
Aug 20161200
Sep 20161400
Oct 20161200
Nov 20161600
Dec 20161100
Jan 2017100
Mar 2017300
Apr 20171000
May 2017900
Jun 2017900
Jul 2017900
Aug 20171100
Sep 2017700
Oct 20171100
Nov 20171500
Dec 20171500
Jan 20182000
Feb 20181400
Mar 20181100
Apr 2018900
May 2018800
Jun 20181200
Jul 20181600
Aug 2018800
Sep 20181303
Oct 20181200
Nov 20181601
Dec 20181100
Jan 20191000
Feb 20191100
Mar 2019900
Apr 20191601
May 20191000
Jun 20191002
Jul 20191100
Aug 2019800
Sep 2019800
Oct 20191300
Nov 2019801
Dec 20191500
Jan 20201200
Feb 20201000
Mar 2020500
Jun 2020100
Jul 2020300
Oct 2020100
Nov 2020300
Dec 2020500
Jan 2021500
Feb 2021300
Mar 2021600
Apr 2021400
May 20212400
Jun 2021400
Jul 20211200
Aug 2021200
Sep 2021300
Oct 20211100
Nov 20211700
Dec 2021500
Jan 20221700
Feb 2022300
Mar 2022400
Apr 2022300
May 2022500
Jun 20221000
Jul 20221100
Aug 2022300
Sep 20221200
Oct 2022500
Nov 2022500
Dec 2022300
Jan 2023600
Feb 20231100
Mar 20231000
Apr 2023500
May 2023400
Jun 2023800
Jul 2023700
Aug 2023400
Sep 2023200

PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 15, Issue 3
1 May 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Structural Characteristics for Inhibition of [3H] Norepinephrine Uptake into Rat Brain Synaptic Vesicles by Beta-Carboline, Indolealkylamine, Phenethylamine and n-Alkylamine Derivatives
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Structural Characteristics for Inhibition of [3H] Norepinephrine Uptake into Rat Brain Synaptic Vesicles by Beta-Carboline, Indolealkylamine, Phenethylamine and n-Alkylamine Derivatives

THEODORE A. SLOTKIN, MARIA SALVAGGIO, FREDERIC J. SEIDLER and WILLIAM L. WHITMORE
Molecular Pharmacology May 1, 1979, 15 (3) 607-619;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Structural Characteristics for Inhibition of [3H] Norepinephrine Uptake into Rat Brain Synaptic Vesicles by Beta-Carboline, Indolealkylamine, Phenethylamine and n-Alkylamine Derivatives

THEODORE A. SLOTKIN, MARIA SALVAGGIO, FREDERIC J. SEIDLER and WILLIAM L. WHITMORE
Molecular Pharmacology May 1, 1979, 15 (3) 607-619;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics